PLAQUENIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Plaquenil, and what generic alternatives are available?
Plaquenil is a drug marketed by Concordia and is included in one NDA.
The generic ingredient in PLAQUENIL is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Plaquenil
A generic version of PLAQUENIL was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.
Summary for PLAQUENIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 105 |
Patent Applications: | 4,292 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PLAQUENIL |
What excipients (inactive ingredients) are in PLAQUENIL? | PLAQUENIL excipients list |
DailyMed Link: | PLAQUENIL at DailyMed |
Recent Clinical Trials for PLAQUENIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yoo-min Kim | Phase 3 |
Ministry of Health & Welfare, Korea | Phase 3 |
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | Phase 2/Phase 3 |
Pharmacology for PLAQUENIL
Drug Class | Antimalarial Antirheumatic Agent |
Anatomical Therapeutic Chemical (ATC) Classes for PLAQUENIL
US Patents and Regulatory Information for PLAQUENIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | PLAQUENIL | hydroxychloroquine sulfate | TABLET;ORAL | 009768-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |